Brain Abnormalities in Late-Onset Major Depression

NCT ID: NCT00260468

Last Updated: 2009-10-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

44 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-11-30

Study Completion Date

2008-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this project is to examine the state of the brain in people over 50 years old suffering from late-onset depression by means of an extensive clinical assessment programme, including magnetic resonance imaging (MRI), neuropsychological testing, neurological examination, eye examination as well as blood and saliva samples. The results are to be compared with results from a control group matched for gender and age.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Major depression is a frequent and serious disorder with different prognoses and complications with respect to lack of treatment response, recurrence and suicide.

MRI of the brain can provide information about changes in the brain tissue with depression, e.g. lesions of nerve connections, small thrombi or changes in the blood flow. These changes appear primarily after the age of 50 and are seen in cases of diabetes and high blood pressure. Furthermore, the connection between disruptions in the body's stress response system and depression will be explored, which is very important since studies indicate that stress and depression can affect certain brain parts permanently. This will give us a better understanding of the connection between brain changes, neuropsychology and depression prognosis, which is decisive for accurate diagnostics, effective treatment and targeted prevention of the disease in the long run.

The project is part of a larger clinical assessment programme in the Neuropsychiatric Unit under the Centre for Basic Psychiatric Research, Aarhus Psychiatric Hospital, Denmark, which gives us unique possibilities of combining research and daily clinical work. The hope is in the future to be able to offer patients in the risk group better assessment and treatment to prevent complications and recurrence.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Major Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Clinical examination program

Psychiatric/clinical interview MRI scan Blood samples Saliva samples Eye examination

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* first time major depression
* age over 50 years
* Caucasian
* admitted at a psychiatric hospital or treated at a local psychiatric clinic in Aarhus Amt

Exclusion Criteria

* major brain damage (e.g. stroke, epilepsy, trauma)
* major alcohol or drug abuse
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Danish Medical Research Council

OTHER

Sponsor Role collaborator

Bayer

INDUSTRY

Sponsor Role collaborator

University of Aarhus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Centre for Psychiatric Research, Aarhus University Hospital, Risskov, Denamrk

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Raben Rosenberg, Professor, MD, DrMedSc

Role: STUDY_DIRECTOR

Aarhus University Hospital

Videbech Poul, Professor, MD, DrMedSc

Role: PRINCIPAL_INVESTIGATOR

Aarhus University Hospital

Leif Østergaard, Professor, MD, DrMedSc, PhD

Role: STUDY_CHAIR

Center for Functionally Integrative Neuroscience (CFIN), Aarhus University Hospital, Denmark

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre for Psychiatric Research, Aarhus University Hospital

Risskov, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Related Links

Access external resources that provide additional context or updates about the study.

http://psykiatriskforskning.dk/index.php?id=8

Centre for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20051050

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Predictors of Cognitive Outcomes in Geriatric Depression
NCT05273996 ACTIVE_NOT_RECRUITING PHASE4
DPA-714 and FDG PET/MRI in Depression
NCT06565936 RECRUITING NA